Salvatore Giovine

2022

In 2022, Salvatore Giovine earned a total compensation of $693.2K as Former Chief Financial Officer at Xilio Therapeutics, a 64% decrease compared to previous year.

Compensation breakdown

Option Awards$436,793
Salary$256,154
Other$252
Total$693,199

Giovine received $436.8K in option awards, accounting for 63% of the total pay in 2022.

Giovine also received $256.2K in salary and $252 in other compensation.

Rankings

In 2022, Salvatore Giovine's compensation ranked 3,788th out of 5,717 executives tracked by ExecPay. In other words, Giovine earned more than 33.7% of executives.

ClassificationRankingPercentile
All
3,788
out of 5,717
34th
Division
Manufacturing
2,144
out of 3,111
31st
Major group
Chemicals And Allied Products
1,030
out of 1,410
27th
Industry group
Drugs
966
out of 1,311
26th
Industry
Pharmaceutical Preparations
705
out of 957
26th
Source: SEC filing on April 25, 2023.

Giovine's colleagues

We found two more compensation records of executives who worked with Salvatore Giovine at Xilio Therapeutics in 2022.

2022

René Russo

Xilio Therapeutics

Chief Executive Officer

2022

Martin Huber

Xilio Therapeutics

President and Head of R&D

News

In-depth

You may also like